CAJ | 학술논문

输血仍旧在肝癌的外科治疗中占有重要地位.然而异体输血可能导致受血者免疫抑制,阻碍机体对肿瘤的免疫应答,促进肿瘤转移复发.如何解决这一矛盾,值得我们的关注.我们要研究异体输血与肝癌肝切除术后转移复发的关系,从而找出对策,改善肝癌患者预后水平.
수혈잉구재간암적외과치료중점유중요지위.연이이체수혈가능도치수혈자면역억제,조애궤체대종류적면역응답,촉진종류전이복발.여하해결저일모순,치득아문적관주.아문요연구이체수혈여간암간절제술후전이복발적관계,종이조출대책,개선간암환자예후수평.
Blood transfusion in liver surgery still plays an important role.However,blood transfusions may cause immunosuppression recipients and hinder the body' s immune response against the tumor,promotes tumor metastasis and recurrence.How to resolve this contradiction? We must study and research the effects of allogeneic blood transfusion on liver cancer metastasis and recurrence after hepatic resection,and to find strategies to improve the liver cancer prognosis.